05/02/16 - 11:46 AM EDT
After reporting a disappointing first quarter on Friday, the biopharma company could regain some value amid court developments over its patent lawsuit with Merck.
04/30/16 - 12:01 PM EDT
Obamacare has hospitals and other health care entities scrambling to get bigger, but the FTC is having more success fighting mergers than ever. What gives?
04/28/16 - 01:55 PM EDT
Cramer remains bullish on drug makers including Johnson & Johnson, Bristol-Myers and Allergan.
04/28/16 - 11:39 AM EDT
Never mind the Ohio health care services company's better-than-anticipated Q3 earnings.
04/28/16 - 10:42 AM EDT
The maker of scientific instruments hiked full-year expectations in light of its $1.3 billion deal for Affymetrix.
04/27/16 - 11:33 AM EDT
The health insurance giant doesn't plan to add to or exit any of its 14 Obamacare exchanges, though that could change if its $54.2 billion acquisition of Cigna is completed.
04/26/16 - 12:16 PM EDT
Analysts are optimistic Verisk's $820 million sale of Verisk Health will provide a long-term boost to the data and risk analytics company's stock.
04/25/16 - 01:31 PM EDT
Pfizer and Allergan scrapped their $160 billion deal to combine earlier this month following a tax clampdown by the Treasury Department.
04/25/16 - 01:00 PM EDT
Joseph Papa has left Perrigo to head up Valeant as its new chief executive.
04/20/16 - 01:46 PM EDT
Under Armour, the athletic-wear maker represented by NBA superstar Stephen Curry, will post earnings Thursday morning before the opening bell.